Base de dados : MEDLINE
Pesquisa : M01.169 [Categoria DeCS]
Referências encontradas : 2147 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 215 ir para página                         

  1 / 2147 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29191154
[Au] Autor:Boettiger DC; Law MG; Dore GJ; Guy R; Callander D; Donovan B; O'Connor CC; Fairley CK; Hellard M; Matthews G
[Ad] Endereço:The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia. dboettiger@kirby.unsw.edu.au.
[Ti] Título:Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.
[So] Source:BMC Infect Dis;17(1):740, 2017 Dec 01.
[Is] ISSN:1471-2334
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Direct acting antivirals are expected to drastically reduce the burden of hepatitis C virus (HCV) in people living with Human Immunodeficiency Virus (HIV). However, rates of HCV testing, re-testing and incident infection in this group remain uncertain in Australia. We assessed trends in HCV testing, re-testing and incident infection among HIV-positive individuals, and evaluated factors associated with HCV re-testing and incident infection. METHODS: The study population consisted of HIV-positive individuals who visited a sexual health service involved in the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS) between 2007 and 2015. Poisson regression was used to assess trends and to evaluate factors associated with HCV re-testing and incident HCV infection. RESULTS: There were 9227 HIV-positive individuals included in our testing rate analysis. Of 3799 HIV-positive/HCV-negative people that attended an ACCESS sexual health service more than once, 2079 (54.7%) were re-tested for HCV and were therefore eligible for our incidence analysis. The rate of HCV testing increased from 17.1 to 51.4 tests per 100 patient years between 2007 and 2015 (p for trend <0.01). Over the same period, HCV re-testing rates increased from 23.9 to 79.7 tests per 100 person years (p for trend <0.01). A clear increase in testing and re-testing began after 2011. Patients who identified as men who have sex with men and those with a history of injecting drug use experienced high rates of HCV re-testing over the course of the study period. Among those who re-tested, 157 incident HCV infections occurred at a rate of 2.5 events per 100 person years. Between 2007 and 2009, 2010-2011, 2012-2013 and 2014-2015, rates of incident HCV were 0.8, 1.5, 3.9 and 2.7 events per 100 person years, respectively (p for trend <0.01). Incident HCV was strongly associated with a history of injecting drug use. CONCLUSIONS: High rates of HCV testing and re-testing among HIV-positive individuals in Australia will assist strategies to achieve HCV elimination through rapid treatment scale up. Continued monitoring of HCV incidence in this population is essential for guiding both HCV prevention and treatment strategies.
[Mh] Termos MeSH primário: Infecções por HIV/diagnóstico
Hepatite C/diagnóstico
[Mh] Termos MeSH secundário: Adulto
Austrália/epidemiologia
Usuários de Drogas
Feminino
Infecções por HIV/complicações
Serviços de Saúde
Hepacivirus/genética
Hepacivirus/imunologia
Hepacivirus/isolamento & purificação
Hepatite C/complicações
Hepatite C/epidemiologia
Anticorpos Anti-Hepatite C/sangue
Homossexualidade
Seres Humanos
Incidência
Masculino
Meia-Idade
RNA Viral/sangue
Vigilância de Evento Sentinela
Saúde Sexual
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Hepatitis C Antibodies); 0 (RNA, Viral)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180306
[Lr] Data última revisão:
180306
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171202
[St] Status:MEDLINE
[do] DOI:10.1186/s12879-017-2848-0


  2 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27771524
[Au] Autor:Panda S; Kumar MS
[Ad] Endereço:National Institute of Cholera & Enteric Diseases (Indian Council of Medical Research), P-33 CIT Road, Scheme-XM, Beliaghata, Kolkata 700010, West Bengal, India.
[Ti] Título:Injecting drug use in India and the need for policy and program change.
[So] Source:Int J Drug Policy;37:115-116, 2016 11.
[Is] ISSN:1873-4758
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Mh] Termos MeSH primário: Legislação de Medicamentos/tendências
Abuso de Substâncias por Via Intravenosa/epidemiologia
[Mh] Termos MeSH secundário: Adulto
Idade de Início
Analgésicos Opioides
Usuários de Drogas
Feminino
Infecções por HIV/epidemiologia
Infecções por HIV/etiologia
Infecções por HIV/prevenção & controle
Redução do Dano
Hepatite C/epidemiologia
Hepatite C/etiologia
Hepatite C/prevenção & controle
Seres Humanos
Índia/epidemiologia
Masculino
Uso Comum de Agulhas e Seringas
Programas de Troca de Agulhas
Abuso de Substâncias por Via Intravenosa/complicações
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics, Opioid)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180226
[Lr] Data última revisão:
180226
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE


  3 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29341568
[Au] Autor:Kostic M; Kocic B; Tiodorovic B
[Ti] Título:Stigmatization and discrimination of patients with chronic hepatitis C.
[So] Source:Vojnosanit Pregl;73(12):1116-24, 2016 Dec.
[Is] ISSN:0042-8450
[Cp] País de publicação:Serbia
[La] Idioma:eng
[Ab] Resumo:Background/Aim: Chronic hepatitis C (CHC) is often associated with injectable drug users and human immunodeficiency virus coinfection for which there is stigmatization in society. The aim of this study was to identify the presence of stigma and discrimination of patients with CHC, as well as the influence of sociodemographic factors on the occurrence of stigmatization. Methods: A cross-sectional study was performed. Patients with CHC and conducted antiviral therapy completed an anonymous structured questionnaire consisting of sociodemographic questions and Hepatitis C stigma scale. Results: Out of 154 patients 61.7% were male and 72.1% from the city; 59.7% have completed secondary school; 61.7% were employed before the disease while 31.8% after the disease; 45.5% were unsatisfactory with financial situation; 54.5% were married; 37.7% lived with a spouse and children; 86.4% in their own house/apartment; 5.2% of the patients were abandoned by their partners, while 35.7% consumed drugs. A statistical significance of the stigma score was found in those who lived in the city (p = 0.018), unmarried (p = 0.005), abandoned by the partners after the diagnosis of CHC (p < 0.001), drug users (p = 0.002) and those living with parents (p = 0.034). Univariate regression analysis singled out as significant: residence (p = 0.018), living with their parents (p = 0.046), abandonment by a partner (p < 0.001) and drug use (p = 0.002). A multivariate regression model of independent variables singled out abandonment by partners (Beta = 5.158, p = 0.007). Men disagree significantly with the two elements inside stigma [not the same as the others (p = 0.035)] and hurt by the reaction of others (p = 0.047)). Conclusion: The presence of stigma in patients with CHC was proven. The results indicate the need to strengthen anti-stigma programs that will reduce their psychological and social problems and reduce stigmatization in society.
[Mh] Termos MeSH primário: Hepatite C Crônica/psicologia
Preconceito
Opinião Pública
Estigma Social
Estereotipagem
[Mh] Termos MeSH secundário: Adolescente
Adulto
Idoso
Distribuição de Qui-Quadrado
Estudos Transversais
Usuários de Drogas/psicologia
Feminino
Hepatite C Crônica/diagnóstico
Hepatite C Crônica/epidemiologia
Seres Humanos
Modelos Lineares
Masculino
Estado Civil
Meia-Idade
Análise Multivariada
Sérvia/epidemiologia
Fatores Socioeconômicos
Transtornos Relacionados ao Uso de Substâncias/epidemiologia
Transtornos Relacionados ao Uso de Substâncias/psicologia
Saúde da População Urbana
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180213
[Lr] Data última revisão:
180213
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180118
[St] Status:MEDLINE
[do] DOI:10.2298/VSP150511135K


  4 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28742182
[Au] Autor:Larsson S; Persson de Fine Licht K
[Ti] Título:De som injicerar droger självklar målgrupp för hepatit C-behandling..
[So] Source:Lakartidningen;114, 2017 Jul 20.
[Is] ISSN:1652-7518
[Cp] País de publicação:Sweden
[La] Idioma:swe
[Mh] Termos MeSH primário: Hepatite C/tratamento farmacológico
Guias de Prática Clínica como Assunto
Abuso de Substâncias por Via Intravenosa/tratamento farmacológico
[Mh] Termos MeSH secundário: Usuários de Drogas
Prioridades em Saúde
Seres Humanos
[Pt] Tipo de publicação:LETTER
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171207
[Lr] Data última revisão:
171207
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170726
[St] Status:MEDLINE


  5 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29049121
[Au] Autor:Ballantyne JC
[Ad] Endereço:From the Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington.
[Ti] Título:Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions.
[So] Source:Anesth Analg;125(5):1769-1778, 2017 Nov.
[Is] ISSN:1526-7598
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:An overreliance on opioids has impacted all types of pain management, making it undoubtedly a root cause of the "epidemic" of prescription opioid abuse in the United States. Yet, an examination of the statistics that led the US Centers for Disease Control and Prevention to declare that prescription opioid abuse had reached epidemic levels shows that the abuse occurrences and deaths are arising outside the hospital or hospice setting, which strongly implicates the outpatient use of opioids to treat chronic pain. Such abuse and related deaths are occurring in chronic pain patients themselves and also through diversion. Overprescribing to outpatients has afforded distressed and vulnerable individuals access to these highly addictive drugs. The focus of this article is on what we have learned since opioid treatment of chronic pain was first popularized at the end of the 20th century and how this new information can guide chronic pain management in the future.
[Mh] Termos MeSH primário: Assistência Ambulatorial/tendências
Analgésicos Opioides/efeitos adversos
Dor Crônica/tratamento farmacológico
Transtornos Relacionados ao Uso de Opioides/prevenção & controle
Padrões de Prática Médica/tendências
Uso Indevido de Medicamentos sob Prescrição/prevenção & controle
Avaliação de Processos (Cuidados de Saúde)/tendências
[Mh] Termos MeSH secundário: Analgésicos Opioides/administração & dosagem
Comportamento Aditivo
Encéfalo/efeitos dos fármacos
Encéfalo/fisiopatologia
Dor Crônica/diagnóstico
Dor Crônica/fisiopatologia
Dor Crônica/psicologia
Prescrições de Medicamentos
Usuários de Drogas/psicologia
Epidemias
Previsões
Seres Humanos
Prescrição Inadequada/prevenção & controle
Transtornos Relacionados ao Uso de Opioides/diagnóstico
Transtornos Relacionados ao Uso de Opioides/epidemiologia
Medição de Risco
Fatores de Risco
Resultado do Tratamento
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Analgesics, Opioid)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171030
[Lr] Data última revisão:
171030
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171020
[St] Status:MEDLINE
[do] DOI:10.1213/ANE.0000000000002500


  6 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29049118
[Au] Autor:Webster LR
[Ad] Endereço:From PRA Health Sciences, Salt Lake City, Utah.
[Ti] Título:Risk Factors for Opioid-Use Disorder and Overdose.
[So] Source:Anesth Analg;125(5):1741-1748, 2017 Nov.
[Is] ISSN:1526-7598
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Opioid analgesics are recognized as a legitimate medical therapy for selected patients with severe chronic pain that does not respond to other therapies. However, opioids are associated with risks for patients and society that include misuse, abuse, diversion, addiction, and overdose deaths. Therapeutic success depends on proper candidate selection, assessment before administering opioid therapy, and close monitoring throughout the course of treatment. Risk assessment and prevention include knowledge of patient factors that may contribute to misuse, abuse, addiction, suicide, and respiratory depression. Risk factors for opioid misuse or addiction include past or current substance abuse, untreated psychiatric disorders, younger age, and social or family environments that encourage misuse. Opioid mortality prevalence is higher in people who are middle aged and have substance abuse and psychiatric comorbidities. Suicides are probably undercounted or frequently misclassified in reports of opioid-related poisoning deaths. Greater understanding and better assessment are needed of the risk associated with suicide risk in patients with pain. Clinical tools and an evolving evidence base are available to assist clinicians with identifying patients whose risk factors put them at risk for adverse outcomes with opioids.
[Mh] Termos MeSH primário: Analgésicos Opioides/efeitos adversos
Dor Crônica/tratamento farmacológico
Overdose de Drogas/epidemiologia
Usuários de Drogas/psicologia
Transtornos Relacionados ao Uso de Opioides/epidemiologia
Uso Indevido de Medicamentos sob Prescrição
[Mh] Termos MeSH secundário: Comportamento Aditivo
Dor Crônica/diagnóstico
Dor Crônica/epidemiologia
Dor Crônica/psicologia
Tomada de Decisão Clínica
Técnicas de Apoio para a Decisão
Overdose de Drogas/diagnóstico
Overdose de Drogas/prevenção & controle
Overdose de Drogas/psicologia
Conhecimentos, Atitudes e Prática em Saúde
Nível de Saúde
Seres Humanos
Saúde Mental
Transtornos Relacionados ao Uso de Opioides/diagnóstico
Transtornos Relacionados ao Uso de Opioides/prevenção & controle
Transtornos Relacionados ao Uso de Opioides/psicologia
Medição da Dor
Seleção de Pacientes
Desvio de Medicamentos sob Prescrição
Uso Indevido de Medicamentos sob Prescrição/prevenção & controle
Uso Indevido de Medicamentos sob Prescrição/psicologia
Medição de Risco
Fatores de Risco
Ideação Suicida
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Analgesics, Opioid)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171030
[Lr] Data última revisão:
171030
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171020
[St] Status:MEDLINE
[do] DOI:10.1213/ANE.0000000000002496


  7 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29016621
[Au] Autor:Paraschiv S; Banica L; Nicolae I; Niculescu I; Abagiu A; Jipa R; Pineda-Peña AC; Pingarilho M; Neaga E; Theys K; Libin P; Otelea D; Abecasis A
[Ad] Endereço:Molecular Diagnostics Laboratory, National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.
[Ti] Título:Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.
[So] Source:PLoS One;12(10):e0185866, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Co-infections with HIV and HCV are very frequent among people who inject drugs (PWID). However, very few studies comparatively reconstructed the transmission patterns of both viruses in the same population. We have recruited 117 co-infected PWID during a recent HIV outbreak in Romania. Phylogenetic analyses were performed on HIV and HCV sequences in order to characterize and compare transmission dynamics of the two viruses. Three large HIV clusters (2 subtype F1 and one CRF14_BG) and thirteen smaller HCV transmission networks (genotypes 1a, 1b, 3a, 4a and 4d) were identified. Eighty (65%) patients were both in HIV and HCV transmission chains and 70 of those shared the same HIV and HCV cluster with at least one other patient. Molecular clock analysis indicated that all identified HIV clusters originated around 2006, while the origin of the different HCV clusters ranged between 1980 (genotype 1b) and 2011 (genotypes 3a and 4d). HCV infection preceded HIV infection in 80.3% of cases. Coincidental transmission of HIV and HCV was estimated to be rather low (19.65%) and associated with an outbreak among PWID during detention in the same penitentiary. This study has reconstructed and compared the dispersion of these two viruses in a PWID population.
[Mh] Termos MeSH primário: Coinfecção/transmissão
Infecções por HIV/transmissão
HIV/genética
Hepacivirus/genética
Hepatite C/transmissão
[Mh] Termos MeSH secundário: Adulto
Coinfecção/epidemiologia
Coinfecção/genética
Coinfecção/virologia
Surtos de Doenças
Usuários de Drogas
Feminino
Genótipo
HIV/patogenicidade
Infecções por HIV/epidemiologia
Infecções por HIV/genética
Infecções por HIV/virologia
Hepacivirus/patogenicidade
Hepatite C/epidemiologia
Hepatite C/genética
Hepatite C/virologia
Seres Humanos
Masculino
Filogenia
Romênia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171031
[Lr] Data última revisão:
171031
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171011
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0185866


  8 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28829854
[Au] Autor:Relhan N; Schwartz SG; Flynn HW
[Ad] Endereço:Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
[Ti] Título:Endogenous Fungal Endophthalmitis: An Increasing Problem Among Intravenous Drug Users.
[So] Source:JAMA;318(8):741-742, 2017 08 22.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Usuários de Drogas
Abuso de Substâncias por Via Intravenosa
[Mh] Termos MeSH secundário: Antifúngicos
Endoftalmite
Infecções Oculares Fúngicas
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL; COMMENT
[Nm] Nome de substância:
0 (Antifungal Agents)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170921
[Lr] Data última revisão:
170921
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170823
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.10585


  9 / 2147 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28750193
[Au] Autor:Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
[Ad] Endereço:1 British Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, British Columbia, Canada.
[Ti] Título:Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
[So] Source:Public Health Rep;132(5):563-569, 2017 Sep/Oct.
[Is] ISSN:1468-2877
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: Although take-home naloxone (THN) programs are integral in strategies to prevent overdose deaths among opioid users, the uptake of THN among people who use drugs (PWUD) (including non-opioid users) is unknown. The objectives of this study were to determine awareness, possession, and use of THN among PWUD in Vancouver, Canada, and identify barriers to adopting this strategy. METHODS: From December 1, 2014, to May 29, 2015, participants in 2 prospective cohort studies of PWUD in Vancouver completed a standardized questionnaire, which asked about awareness, possession, and use of THN; sociodemographic characteristics; and drug use patterns. We conducted multivariable logistic regression analyses to determine factors independently associated with awareness and possession of THN. RESULTS: Of 1137 PWUD, 727 (64%) reported at least 1 previous overdose ever, and 220 (19%) had witnessed an overdose in the previous 6 months. Although 769 (68%) participants overall reported awareness of THN, only 88 of 392 (22%) opioid users had a THN kit, 18 (20%) of whom had previously administered naloxone. Factors that were positively associated with awareness of THN included witnessing an overdose in the previous 6 months (adjusted odds ratio [aOR] = 2.23; 95% confidence interval [CI], 1.49-3.34; P < .001), possession of THN (aOR = 1.85; 95% CI, 1.11-3.06; P = .02), younger age (aOR = 1.02; 95% CI, 1.01-1.04; P = .003), white race (aOR = 1.67; 95% CI, 1.27-2.19; P < .001), hepatitis C infection (aOR = 1.63; 95% CI, 1.13-2.36; P = .01), residing in Vancouver's Downtown Eastside neighborhood (aOR = 1.93; 95% CI, 1.47-2.53; P < .001), and at least daily heroin injection (aOR = 1.69; 95% CI, 1.09-2.62; P < .02). CONCLUSION: Efforts to improve knowledge of and participation in the THN program may contribute to reduced opioid overdose mortality in Vancouver.
[Mh] Termos MeSH primário: Conscientização
Usuários de Drogas
Naloxona/uso terapêutico
Antagonistas de Entorpecentes/uso terapêutico
Autoadministração
Drogas Ilícitas
[Mh] Termos MeSH secundário: Colúmbia Britânica
Overdose de Drogas/tratamento farmacológico
Overdose de Drogas/prevenção & controle
Feminino
Seres Humanos
Masculino
Meia-Idade
Estudos Prospectivos
Inquéritos e Questionários
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Narcotic Antagonists); 0 (Street Drugs); 36B82AMQ7N (Naloxone)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170930
[Lr] Data última revisão:
170930
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170728
[St] Status:MEDLINE
[do] DOI:10.1177/0033354917717230


  10 / 2147 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
[PMID]:28724038
[Au] Autor:Antonio N; Diehl A; Niel M; Pillon S; Ratto L; Pinheiro MC; Silveira D; Otani TZ; Otani V; Cordeiro Q; Ushida R
[Ad] Endereço:Center for Integrated Mental Health (CAISM), Faculdade de Ciências Médicas da Santa Casa de São Paulo (FCMSCSP), São Paulo, SP, Brazil.
[Ti] Título:Sexual addiction in drug addicts: The impact of drug of choice and poly-addiction.
[So] Source:Rev Assoc Med Bras (1992);63(5):414-421, 2017 May.
[Is] ISSN:1806-9282
[Cp] País de publicação:Brazil
[La] Idioma:eng
[Ab] Resumo:Objective:: To compare the risk of comorbid sexual addiction in a sample of individuals with a diagnosis of substance dependence, stratifying the sample by drug of choice as well as by mono versus polysubstance addiction. Method:: All data were collected at Santa Casa de São Paulo, Brazil. The study sample comprised all alcohol or drug dependents admitted to the Addiction Treatment Unit between November 2013 and August 2014. A generalized linear model with a binomial distribution was performed to compare the odds of having a Sexual Addiction Screening Test (SAST) score greater than 6 points in the subgroups analyzed. Results:: A total of 133 participants were included in our analysis, all reporting cocaine/crack and/or alcohol as drug of choice. Polysubstance addicts had a significant higher risk of a positive screening for sexual addiction compared to monosubstance addicts, age-sex adjusted odds ratios of sexual addiction being respectively 2.72 (95CI 1.1-6.71) and 0.37 (95CI 0.15-0.91). The odds of a SAST score greater than 6 was not statistically different between the cocaine/crack and alcohol groups, respectively 0.38 (95CI 0.14-1.02) and 2.67 (95CI 0.98-7.25). We found a significant relation between stronger drug addiction and greater levels of sexual addiction in the cocaine/crack group (p=0.0012), but not in the alcohol group. Conclusion:: Our study reinforces the importance of assessing sexual behavior of drug addicts in clinical practice, especially considering users of multiple substances or with severe dependence.
[Mh] Termos MeSH primário: Transtornos Relacionados ao Uso de Álcool/complicações
Comportamento Aditivo/induzido quimicamente
Transtornos Relacionados ao Uso de Cocaína/complicações
Medição de Risco/métodos
Comportamento Sexual/efeitos dos fármacos
Disfunções Sexuais Psicogênicas/induzido quimicamente
[Mh] Termos MeSH secundário: Adulto
Fatores Etários
Transtornos Relacionados ao Uso de Álcool/psicologia
Comportamento Aditivo/psicologia
Brasil
Transtornos Relacionados ao Uso de Cocaína/psicologia
Cocaína Crack/efeitos adversos
Usuários de Drogas/psicologia
Feminino
Seres Humanos
Modelos Logísticos
Masculino
Meia-Idade
Escalas de Graduação Psiquiátrica
Fatores de Risco
Índice de Gravidade de Doença
Fatores Sexuais
Comportamento Sexual/psicologia
Fatores Socioeconômicos
Inquéritos e Questionários
[Pt] Tipo de publicação:JOURNAL ARTICLE; OBSERVATIONAL STUDY
[Nm] Nome de substância:
0 (Crack Cocaine)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170929
[Lr] Data última revisão:
170929
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170721
[St] Status:MEDLINE



página 1 de 215 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde